NCT02499952 2022-07-11Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell TumorsHoosier Cancer Research NetworkPhase 2 Terminated12 enrolled 14 charts
NCT00332280 2013-03-20Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus PlaceboAuron Healthcare GmbHPhase 2/3 Terminated67 enrolled